TY - JOUR
T1 - Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapy
AU - Speight, Jane
AU - Hussain, Sufyan
AU - Anandhakrishnan, Ananthi
AU - Danne, Thomas
AU - Latres, Esther
AU - Karpen, Stephen R.
AU - Mytkolli, Linxi
AU - Scibilia, Renza
AU - Soeholm, Uffe
AU - Senior, Peter A.
AU - Vallis, Michael
AU - de Wit, Maartje
AU - Read, Meaghan
AU - Press, Chanel
AU - Pokerznik, Mary Anna
AU - Piemonti, Lorenzo
AU - Nutt, Dominic
AU - McLeod, Heather
AU - Marinac, Marjana
AU - Lally, Julianne
AU - Keighron, Cameron
AU - Jefferson, Stephen
AU - del Pozo, Carmen Hurtado
AU - Heller, Simon R.
AU - Greeno, Brianna
AU - Gibson, Kathleen
AU - Forbes, Shareen
AU - Ehrmann, Dominic
AU - Dutta, Sanjoy
AU - Cooke, Debbie
AU - Cleal, Bryan
AU - Berishvili, Ekaterina
AU - Albanese-O’Neill, Anastasia
AU - Ahnstedt, Hilda
AU - Adams, Dawn
AU - Breakthrough T1D PROMISE Workshop Group
N1 - Publisher Copyright:
© Springer Nature America, Inc. 2026.
PY - 2026/3
Y1 - 2026/3
N2 - Stem-cell-derived islet cells could transform type 1 diabetes by removing the need for injected or infused insulin and improving quality of life. But evaluation of these therapies must center on the voices of people living with type 1 diabetes and examine meaningful outcomes.
AB - Stem-cell-derived islet cells could transform type 1 diabetes by removing the need for injected or infused insulin and improving quality of life. But evaluation of these therapies must center on the voices of people living with type 1 diabetes and examine meaningful outcomes.
UR - https://www.scopus.com/pages/publications/105032160954
U2 - 10.1038/s41591-026-04201-3
DO - 10.1038/s41591-026-04201-3
M3 - Comment/debate
C2 - 41708924
AN - SCOPUS:105032160954
SN - 1078-8956
VL - 32
SP - 797
EP - 801
JO - Nature Medicine
JF - Nature Medicine
IS - 3
ER -